In the news:Wuxi AppTec and Wuxi Biologics drop on passage of US bill targeting China biotech firms
WuXi Biologics
Bookmark
ShareCopied to clipboardWuXi Biologics is a company. It is a public company in Wuxi, China. It was founded in 2014 and its current CEO is Zhisheng Chen. It is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Wuxi
- country: China
- employees: 9,864 people
- revenues: 1.5B $
- company type: public
- sector: Health Care
- industry: Biotechnology
- foundation year: 2014
- CEO: Zhisheng Chen
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about WuXi Biologics:
Dataset of stocks from WuXi Biologics:
WuXi Biologics is one of the companies in China, companies in Biotechnology, companies in Health Care, companies in Wuxi and 3,456,835 companies in our database.
Talking Points
- A leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing
- WuXi Biologics, a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions.
- A true global single-source drug development technology platform from concept to commercialization. | Our Vision: "Every drug can be made and every disease can be treated" by building an open-access platform with the most comprehensive capabilities and technologies in the global biologics industry. Our Mission: To accelerate and transform the ...
- WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.